RJFSA
ALIM

Raymond James Financial Services Advisors’s Alimera Sciences ALIM Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,513
Closed -$83K – 2404
2016
Q2 		$83K Hold
4,513
– – ﹤0.01% 2125
2016
Q1 		$118K Buy
+4,513
New +$141K ﹤0.01% 1887

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raymond James Financial Services Advisors's ALIM Position: Q3 2016 in Review

Raymond James Financial Services Advisors sold out of Alimera Sciences (ALIM) in Q3 2016, closing a stake of 4,513 shares — an estimated $83K sold.

Raymond James Financial Services Advisors first reported a position in ALIM in Q1 2016 and held it in 2 quarters. The position peaked at $118K in Q1 2016. 54 funds tracked by Wall St. Rank hold ALIM as of Q3 2016.

  • Raymond James Financial Services Advisors reported no remaining Alimera Sciences position as of Q3 2016 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 4,513 Alimera Sciences shares in Q3 2016, an estimated $83K.
  • Raymond James Financial Services Advisors first reported a position in Alimera Sciences in Q1 2016 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Alimera Sciences position peaked at $118K in Q1 2016.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2016.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.